• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

驱动蛋白超家族:在乳腺癌中的作用、患者预后和治疗学。

Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.

机构信息

School of Anatomy, Human Biology and Physiology, University of Western Australia, Crawley, WA, Australia.

Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

出版信息

Oncogene. 2018 Feb 15;37(7):833-838. doi: 10.1038/onc.2017.406. Epub 2017 Oct 23.

DOI:10.1038/onc.2017.406
PMID:29059174
Abstract

Breast cancer pathobiology is known to be influenced by the differential expression of a group of proteins called the kinesin superfamily (KIFs), which is instrumental in the intracellular transport of chromosomes along microtubules during mitosis. During cellular division, kinesins are strictly regulated through temporal synthesis so that they are present only when needed. However, their misregulation may contribute to uncontrolled cell growth owing to premature sister chromatid separation, highlighting their importance in cancer. This review covers the functions of kinesins in normal and breast cancer cells, the use of kinesins for breast cancer patient prognosis, and the targeting of these molecules for therapeutics. A better understanding of KIF proteins may be pivotal to improved disease outcomes for breast cancer patients.

摘要

乳腺癌的病理生物学已知受到一组称为驱动蛋白超家族 (KIFs) 的蛋白质的差异表达的影响,该家族在有丝分裂期间沿着微管对染色体的细胞内运输至关重要。在细胞分裂过程中,通过时间合成严格调节驱动蛋白,以使它们仅在需要时存在。然而,由于姐妹染色单体过早分离,它们的失调可能导致不受控制的细胞生长,这凸显了它们在癌症中的重要性。本综述涵盖了驱动蛋白在正常和乳腺癌细胞中的功能、驱动蛋白在乳腺癌患者预后中的应用,以及针对这些分子的治疗靶向。更好地了解 KIF 蛋白可能对改善乳腺癌患者的疾病结局至关重要。

相似文献

1
Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.驱动蛋白超家族:在乳腺癌中的作用、患者预后和治疗学。
Oncogene. 2018 Feb 15;37(7):833-838. doi: 10.1038/onc.2017.406. Epub 2017 Oct 23.
2
Chromokinesin: Kinesin superfamily regulating cell division through chromosome and spindle.染色体驱动蛋白:通过染色体和纺锤体调节细胞分裂的驱动蛋白超家族。
Gene. 2016 Sep 1;589(1):43-48. doi: 10.1016/j.gene.2016.05.026. Epub 2016 May 16.
3
Overexpression of kinesins mediates docetaxel resistance in breast cancer cells.驱动蛋白的过表达介导乳腺癌细胞对多西他赛的耐药性。
Cancer Res. 2009 Oct 15;69(20):8035-42. doi: 10.1158/0008-5472.CAN-09-1224. Epub 2009 Sep 29.
4
Kinesins and cancer.驱动蛋白与癌症。
Nat Rev Cancer. 2012 Jul 24;12(8):527-39. doi: 10.1038/nrc3310.
5
Molecular motor proteins of the kinesin superfamily proteins (KIFs): structure, cargo and disease.驱动蛋白超家族蛋白(KIFs)的分子运动蛋白:结构、货物运输与疾病
J Korean Med Sci. 2004 Feb;19(1):1-7. doi: 10.3346/jkms.2004.19.1.1.
6
All kinesin superfamily protein, KIF, genes in mouse and human.小鼠和人类中所有驱动蛋白超家族蛋白(KIF)基因。
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7004-11. doi: 10.1073/pnas.111145398.
7
Roles of kinesin superfamily proteins in colorectal cancer carcinogenesis (Review).驱动蛋白超家族蛋白在结直肠癌发生中的作用(综述)
Oncol Rep. 2021 Jul;46(1). doi: 10.3892/or.2021.8072. Epub 2021 May 6.
8
New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations.帕普罗系列新型MKLP-2抑制剂:设计、合成及生物学评价
Bioorg Med Chem. 2016 Feb 15;24(4):721-34. doi: 10.1016/j.bmc.2015.12.042. Epub 2015 Dec 24.
9
Small Molecule Approach to Study the Function of Mitotic Kinesins.研究有丝分裂驱动蛋白功能的小分子方法。
Methods Mol Biol. 2016;1413:283-99. doi: 10.1007/978-1-4939-3542-0_18.
10
Kinesin superfamily proteins and the regulation of microtubule dynamics in morphogenesis.驱动蛋白超家族蛋白与形态发生中微管动力学的调控
Anat Sci Int. 2015 Jan;90(1):1-6. doi: 10.1007/s12565-014-0259-5. Epub 2014 Oct 28.

引用本文的文献

1
The multifaceted role of KIF15 in cancer progression and therapy.驱动蛋白家族成员15(KIF15)在癌症进展和治疗中的多方面作用
Invest New Drugs. 2025 Aug 16. doi: 10.1007/s10637-025-01572-1.
2
m6A-modified circCCAR1 promotes malignant proliferation by enhancing KIF5B expression in hepatocellular carcinoma.m6A修饰的环状CCAR1通过增强肝细胞癌中KIF5B的表达促进恶性增殖。
J Physiol Biochem. 2025 Jul 23. doi: 10.1007/s13105-025-01112-8.
3
From Motor Proteins to Oncogenic Factors: The Evolving Role of Kinesin Superfamily Proteins in Breast Cancer Development.

本文引用的文献

1
Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer.驱动蛋白家族成员18A在浸润性乳腺癌中的表达与临床病理的相关性
Oncol Lett. 2016 Sep;12(3):1909-1914. doi: 10.3892/ol.2016.4823. Epub 2016 Jul 7.
2
KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL.KSP抑制剂SB743921通过调节p53、Bcl-2和DTL来抑制乳腺癌细胞的生长并诱导其凋亡。
Anticancer Drugs. 2016 Oct;27(9):863-72. doi: 10.1097/CAD.0000000000000402.
3
The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.
从运动蛋白到致癌因子:驱动蛋白超家族蛋白在乳腺癌发展中不断演变的作用
Mol Biotechnol. 2025 Mar 27. doi: 10.1007/s12033-025-01428-2.
4
Targeting Kinesins for Therapeutic Exploitation of Chromosomal Instability in Lung Cancer.靶向驱动蛋白以治疗性利用肺癌中的染色体不稳定
Cancers (Basel). 2025 Feb 18;17(4):685. doi: 10.3390/cancers17040685.
5
The Kinesin Eg5 Inhibitor K858 Enhances Radiosensitivity in Esophageal Squamous Cell Carcinoma and Affects the Expression of Epithelial-mesenchymal Transition Related Markers: and Studies.驱动蛋白Eg5抑制剂K858增强食管鳞状细胞癌的放射敏感性并影响上皮-间质转化相关标志物的表达:体内和体外研究
Anticancer Agents Med Chem. 2025;25(15):1142-1159. doi: 10.2174/0118715206373782250211104402.
6
KIF18B: an important role in signaling pathways and a potential resistant target in tumor development.驱动蛋白家族成员18B(KIF18B):在信号通路中起重要作用,是肿瘤发生发展中的潜在耐药靶点。
Discov Oncol. 2024 Sep 11;15(1):430. doi: 10.1007/s12672-024-01330-4.
7
Kinesin 26B modulates M2 polarization of macrophage by activating cancer-associated fibroblasts to aggravate gastric cancer occurrence and metastasis.驱动蛋白 26B 通过激活癌相关成纤维细胞来调节巨噬细胞 M2 极化,从而加重胃癌的发生和转移。
World J Gastroenterol. 2024 May 28;30(20):2689-2708. doi: 10.3748/wjg.v30.i20.2689.
8
KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.KIF22 通过调控 CDC25C/CDK1/细胞周期蛋白 B1 通路促进多发性骨髓瘤的进展。
J Cancer Res Clin Oncol. 2024 May 7;150(5):239. doi: 10.1007/s00432-024-05747-w.
9
RFC3 drives the proliferation, migration, invasion and angiogenesis of colorectal cancer cells by binding KIF14.RFC3通过与KIF14结合来驱动结肠癌细胞的增殖、迁移、侵袭和血管生成。
Exp Ther Med. 2024 Mar 22;27(5):222. doi: 10.3892/etm.2024.12510. eCollection 2024 May.
10
Ginsenoside 20(S)-Rg3 reduces expression and promotes CDC25A proteasomal degradation in epithelial ovarian cancer.人参皂苷20(S)-Rg3降低上皮性卵巢癌中CDC25A的表达并促进其蛋白酶体降解。
J Ginseng Res. 2024 Jan;48(1):40-51. doi: 10.1016/j.jgr.2023.06.008. Epub 2023 Jul 4.
驱动蛋白Eg5抑制剂K858可诱导乳腺癌细胞凋亡,但也会引发与生存素相关的化疗耐药性。
Invest New Drugs. 2016 Aug;34(4):399-406. doi: 10.1007/s10637-016-0345-8. Epub 2016 Mar 19.
4
Discovery of a novel inhibitor of kinesin-like protein KIFC1.新型驱动蛋白样蛋白KIFC1抑制剂的发现
Biochem J. 2016 Apr 15;473(8):1027-35. doi: 10.1042/BJ20150992. Epub 2016 Feb 4.
5
Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle.Nek2对Kif24的激活作用确保了细胞周期中纤毛的解体。
Nat Commun. 2015 Aug 20;6:8087. doi: 10.1038/ncomms9087.
6
Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF-β signaling.抑制运动蛋白KIF3C的表达通过抑制转化生长因子-β信号传导来抑制乳腺癌的肿瘤生长和转移。
Cancer Lett. 2015 Nov 1;368(1):105-114. doi: 10.1016/j.canlet.2015.07.037. Epub 2015 Aug 10.
7
KIFC1 is a novel potential therapeutic target for breast cancer.驱动蛋白家族成员C1(KIFC1)是乳腺癌一个新的潜在治疗靶点。
Cancer Biol Ther. 2015;16(9):1316-22. doi: 10.1080/15384047.2015.1070980. Epub 2015 Jul 15.
8
Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.紫杉醇通过靶向FOXM1来调节有丝分裂灾难和乳腺癌紫杉醇耐药中的KIF20A。
Oncogene. 2016 Feb 25;35(8):990-1002. doi: 10.1038/onc.2015.152. Epub 2015 May 11.
9
Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features.3,4-二氢嘧啶-2(1H)-酮衍生物对驱动蛋白Eg5的抑制作用对各种乳腺癌细胞特征的影响。
BMC Cancer. 2015 Apr 14;15:283. doi: 10.1186/s12885-015-1274-1.
10
HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients.在乳腺癌患者中,HSET过表达通过不依赖中心体聚集的机制推动肿瘤进展。
Oncotarget. 2015 Mar 20;6(8):6076-91. doi: 10.18632/oncotarget.3475.